CLIMB BIO INC (CLYM) Stock Earnings & Estimates
USA - NASDAQ:CLYM - US28658R1068 - Common Stock
1.94 USD
+0.04 (+2.11%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 400.00% | N/A 200.00% | N/A 270.00% | N/A 141.80% | N/A 115.09% | |||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -7.45M | -20.93M -180.94% | -35.67M -70.43% | -45.14M -26.55% | -21.466M 52.45% | -27.003M -25.79% | N/A -121.23% | N/A -8.44% | N/A -36.31% | N/A 18.28% | N/A 0.25% | N/A 142.51% | N/A 103.33% | N/A 47.54% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.72 73.28% | N/A 22.91% | N/A -20.77% | N/A 52.87% | N/A 1.58% | N/A -29.41% | N/A -15.65% | N/A -34.86% | N/A | N/A | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.18 -38.62% | -0.19 39.95% | -0.19 -45.15% | -0.19 -2.00% | -0.19 -7.55% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -15.138M -100.42% | -14.858M 35.45% | -13.872M -29.92% | -14.28M 4.11% | -14.688M 2.97% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.19 | -0.15 | -0.04 | -27.00% |
| Q2 2025 Q2Q % growth | -0.13 | -0.19 | 0.06 | 31.11% |
| Q1 2025 Q2Q % growth | -0.31 | -0.15 | -0.16 | -102.61% |
| Q4 2024 Q2Q % growth | -0.13 30.48% | -0.15 | 0.02 | 15.03% |
| Q4 2023 Q2Q % growth | 35.52% | -0.19 | % | |
| Q3 2023 Q2Q % growth | 49.46% | -0.19 | % | |
| Q2 2023 Q2Q % growth | 63.57% | -0.20 | % | |
| Q1 2023 Q2Q % growth | -0.25 50.00% | -0.26 | 0.01 | 1.96% |
| Q4 2022 Q2Q % growth | -0.29 27.50% | -0.39 | 0.10 | 25.18% |
| Q3 2022 Q2Q % growth | -0.37 47.14% | -0.44 | 0.07 | 16.13% |
| Q2 2022 Q2Q % growth | -0.56 81.99% | -0.48 | -0.08 | -17.65% |
| Q1 2022 Q2Q % growth | -0.50 | -0.57 | 0.07 | 12.98% |
| Q4 2021 Q2Q % growth | -0.40 | -0.63 | 0.23 | 36.75% |
| Q3 2021 Q2Q % growth | -0.70 | -0.94 | 0.24 | 25.67% |
| Q2 2021 Q2Q % growth | -3.11 | -1.90 | -1.21 | -63.49% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -13.98% | 15.87% | 0.34% | 17.78% |
| Revenue | N/A | N/A | N/A | N/A |